These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20659052)
61. The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudy. Mortensen PT; Herre JM; Chung ES; Bax JJ; Gerritse B; Kruijshoop M; Murillo J Europace; 2010 Dec; 12(12):1750-6. PubMed ID: 20852290 [TBL] [Abstract][Full Text] [Related]
62. Which place for ivabradine in Duchenne muscular dystrophy with heart failure? Fayssoil A Int J Cardiol; 2016 Nov; 223():768-769. PubMed ID: 27573604 [No Abstract] [Full Text] [Related]
63. The paced electrocardiogram cannot be used to identify left and right ventricular pacing sites in cardiac resynchronization therapy: validation by cardiac computed tomography. Sommer A; Kronborg MB; Witt CT; Nørgaard BL; Nielsen JC Europace; 2015 Mar; 17(3):432-8. PubMed ID: 25480941 [TBL] [Abstract][Full Text] [Related]
64. Efficacy of a tool combining guide-wire and stylet for the left ventricular lead positioning. Giannola G; Iacopino S; Lombardo E; Cesario A; Di Stefano G; Piraino LG; Campisi G; Torcivia R; Corrao D; Risi A; Denaro A; Valsecchi S; Europace; 2011 Feb; 13(2):244-50. PubMed ID: 21131651 [TBL] [Abstract][Full Text] [Related]
65. [X-ray characteristics of heart failure in patients with acute myocardial infarction]. Tsallagova ZS; Savchenko AP Vestn Rentgenol Radiol; 1997; (5):4-7. PubMed ID: 9412049 [TBL] [Abstract][Full Text] [Related]
70. Three-dimensional propagation imaging of left ventricular activation by speckle-tracking echocardiography to predict responses to cardiac resynchronization therapy. Seo Y; Ishizu T; Kawamura R; Yamamoto M; Kuroki K; Igarashi M; Sekiguchi Y; Nogami A; Aonuma K J Am Soc Echocardiogr; 2015 May; 28(5):606-14. PubMed ID: 25797706 [TBL] [Abstract][Full Text] [Related]
75. Ventilatory gas exchange and early response to cardiac resynchronization therapy. Kim CH; Olson LJ; Shen WK; Cha YM; Johnson BD J Heart Lung Transplant; 2015 Nov; 34(11):1430-5. PubMed ID: 26163155 [TBL] [Abstract][Full Text] [Related]
76. Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria. Cappelli F; Morini S; Pieragnoli P; Targetti M; Stefàno P; Marchionni N; Olivotto I J Am Coll Cardiol; 2018 Jan; 71(4):464-466. PubMed ID: 29389365 [No Abstract] [Full Text] [Related]
77. [Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications]. Camino Willhuber GO; Guzman Mentesana G; Baez A; Lo Presti S; Bazán C; Strauss M; Fretes R; Paglini-Oliva PA; Rivarola HW Rev Fac Cien Med Univ Nac Cordoba; 2017 Sep; 74(3):231-238. PubMed ID: 29890097 [TBL] [Abstract][Full Text] [Related]
78. Deleterious effects of right ventricular apical pacing in patients with normal ejection fraction: implications of potential expanding epidemic. Butrous H; Pai SM; Pai RG Echocardiography; 2013 Oct; 30(9):995-6. PubMed ID: 23906056 [No Abstract] [Full Text] [Related]
79. Association of ventricular-arterial interaction with the response to cardiac resynchronization therapy. Karamichalakis N; Ikonomidis I; Parissis J; Simitsis P; Filippatos G Eur J Heart Fail; 2021 Jul; 23(7):1238-1240. PubMed ID: 33837617 [No Abstract] [Full Text] [Related]
80. Right ventricular only pacing for cardiac resynchronization therapy. Hermes-Laufer J; Hofer D; Flammer A; Ruschitzka F; Steffel J; Winnik S Europace; 2022 Jan; 24(1):70-71. PubMed ID: 34389862 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]